A first-in-class artificial intelligence-based solution that enables healthcare professionals to detect heart murmurs on a personal mobile device has received clearance from the FDA.
AliveCor announced that the FDA has cleared a new iteration of their KardiaMobile device, the KardiaMobile 6L, the first 6-lead personal electrocardiogram (ECG) device.
The Food and Drug Administration (FDA) has cleared KardiaMobile (AliveCor), a personal ECG device, for use in detecting bradycardia and tachycardia.
There are a limited number of devices that have been cleared by the FDA for head injury assessment.
Kognito, a health simulation company, is applying its simulation technology to patient education, to address a gap in patient knowledge.
Screen time is associated with poorer performance on developmental screening tests among young children, according to a study published online January 28 in JAMA Pediatrics.
“It did not surprise us that they found virtual visits more convenient, but we were impressed that nearly all perceived the quality of care or communication to be the same or better than at the traditional and familiar office visits,” said the lead researcher, Karen Donelan, ScD.
In a report published in the January issue of Value in Health, an ISPOR-The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in 3 areas of health technology assessment (HTA).
The uEXPLORER combines positron emission tomography (PET) with X-ray computed tomography (CT) allowing for imaging of the entire body at the same time.
Wearable sensor data extracted from a fear induction task paired with machine learning can accurately identify young children with internalizing diagnosis.
